EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines

Pirjo Nummela iD, Sadia Zafar iD, Erika Veikkolainen iD, Iiris Ukkola iD, Vincenzo Cinella iD, Abiodun Ayo iD, Muhammad Yasir Asghar iD, Niko Välimäki, Kid Törnquist, Auli Karhu, Pirjo Laakkonen, Lauri A Aaltonen und 1 weitere

International Journal of Cancer · 2024

DOI: 10.1002/ijc.34865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Pirjo Nummela und 12 weiteren Autor:innen. Beteiligte Einrichtung: Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Chromogranins, Colorectal Neoplasms, Cyclic Nucleotide Phosphodiesterases, Type 4, GTP-Binding Protein alpha Subunits, Gs. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Syöpäsäätiö, Medicinska Understödsföreningen Liv och Hälsa, Finska Läkaresällskapet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Approximately 5% of colorectal cancers (CRCs) have a gain‐of‐function mutation in the GNAS gene, which leads to the activation of cAMP‐dependent signaling pathways and associates with poor prognosis. We investigated the effect of an activating GNAS mutation in CRC cell lines on gene expression and cell proliferation in vitro, and tumor growth in vivo. GNAS ‐mutated (GNASmt) HCT116 cells showed stimulated synthesis of cAMP as compared to parental (Par) cells. The most upregulated gene in the GNASmt cells was cAMP‐hydrolyzing phosphodiesterase 4D ( PDE4D) as detected by RNA sequencing. To further validate our finding, we analyzed PDE4D expression in a set of human CRC tumors (n = 35) and demonstrated overexpression in GNAS mutant CRC tumors as compared to GNAS wild‐type tumors. The GNASmt HCT116 cells proliferated more slowly than the Par cells. PDE4 inhibitor Ro 20‐1724 and PDE4D subtype selective inhibitor GEBR‐7b further suppressed the proliferation of GNASmt cells without an effect on Par cells. The growth inhibitory effect of these inhibitors was also seen in the intrinsically GNAS ‐mutated SK‐CO‐1 CRC cell line having high levels of cAMP synthesis and PDE4D expression. In vivo , GNASmt HCT116 cells formed smaller tumors than the Par cells in nude mice. In conclusion, our findings demonstrate that GNAS mutation results in the growth suppression of CRC cells. Moreover, the GNAS mutation‐induced overexpression of PDE4D provides a potential avenue to impede the proliferation of CRC cells through the use of PDE4 inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChromograninsColorectal NeoplasmsCyclic Nucleotide Phosphodiesterases, Type 4GTP-Binding Protein alpha Subunits, GsAnimalsHumansMiceHCT116 CellsMice, NudeMutationPhosphodiesterase 4 Inhibitors

Stichwörter der Autor:innen

GNASPDE4cAMPcolorectal cancerphosphodiesterase

Substanzen

ChromograninsCyclic Nucleotide Phosphodiesterases, Type 4GNAS protein, humanGTP-Binding Protein alpha Subunits, GsPhosphodiesterase 4 InhibitorsPDE4D protein, human

Autor:innen und Institutionen

  • Applied Tumor Genomics Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Department of Pathology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Translational Cancer Medicine Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland.
  • Cell and Tissue Dynamics Research Program, Institute of Biotechnology, HiLife, University of Helsinki, Helsinki, Finland.
  • Minerva Foundation Institute for Medical Research, Helsinki, Finland.
  • Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.

ORCID-Profile: Pirjo Nummela, Sadia Zafar, Erika Veikkolainen, Iiris Ukkola, Vincenzo Cinella, Abiodun Ayo, Muhammad Yasir Asghar, Ari Ristimäki

Förderung

  • Syöpäsäätiö
  • Medicinska Understödsföreningen Liv och Hälsa
  • Finska Läkaresällskapet
  • Helsingin Yliopisto
  • Helsingin ja Uudenmaan Sairaanhoitopiiri
  • Sigrid Juséliuksen Säätiö

Zitieren

APA

Nummela, P., Zafar, S., Veikkolainen, E., Ukkola, I., Cinella, V., Ayo, A., Asghar, M. Y., Välimäki, N., Törnquist, K., Karhu, A., Laakkonen, P., Aaltonen, L. A., & Ristimäki, A. (2024). GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International Journal of Cancer. https://doi.org/10.1002/ijc.34865

Vancouver

Nummela P, Zafar S, Veikkolainen E, Ukkola I, Cinella V, Ayo A, et al. GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines. International Journal of Cancer. 2024. doi:10.1002/ijc.34865

BibTeX
@article{Nummela2024,
  author = {Nummela, Pirjo and Zafar, Sadia and Veikkolainen, Erika and Ukkola, Iiris and Cinella, Vincenzo and Ayo, Abiodun and Asghar, Muhammad Yasir and Välimäki, Niko and Törnquist, Kid and Karhu, Auli and Laakkonen, Pirjo and Aaltonen, Lauri A and Ristimäki, Ari},
  title = {GNAS mutation inhibits growth and induces phosphodiesterase 4D expression in colorectal cancer cell lines},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.34865}
}
Kostenlos starten →